Krilogy Financial’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.96M Sell
198,736
-8,409
-4% -$211K 0.14% 116
2026
Q2
$5.23M Buy
207,145
+1,259
+0.6% +$31.8K 0.15% 113
2026
Q1
$5.21M Buy
205,886
+334
+0.2% +$8.49K 0.17% 106
2025
Q4
$5.24M Buy
205,552
+6,077
+3% +$155K 0.18% 96
2025
Q3
$5.06M Buy
199,475
+23,073
+13% +$586K 0.19% 87
2025
Q2
$4.48M Buy
176,402
+31,155
+21% +$785K 0.26% 82
2025
Q1
$3.67M Buy
145,247
+1,226
+0.9% +$30.7K 0.24% 88
2024
Q4
$3.59M Buy
144,021
+12,892
+10% +$324K 0.24% 87
2024
Q3
$3.35M Sell
131,129
-25,486
-16% -$643K 0.23% 98
2024
Q2
$3.88M Buy
156,615
+1,239
+0.8% +$30.5K 0.29% 78
2024
Q1
$3.87M Buy
155,376
+4,339
+3% +$108K 0.3% 76
2023
Q4
$3.79M Buy
151,037
+5,434
+4% +$132K 0.32% 72
2023
Q3
$3.5M Buy
145,603
+1,674
+1% +$40.7K 0.32% 74
2023
Q2
$3.53M Buy
143,929
+811
+0.6% +$20.1K 0.32% 75
2023
Q1
$3.57M Buy
143,118
+86,157
+151% +$2.13M 0.3% 75
2022
Q4
$1.38M Sell
56,961
-75,960
-57% -$1.83M 0.13% 130
2022
Q3
$3.16M Buy
132,921
+682
+0.5% +$17K 0.38% 43
2022
Q2
$3.3M Buy
132,239
+49,754
+60% +$1.26M 0.38% 43
2022
Q1
$2.17M Sell
82,485
-57,264
-41% -$1.56M 0.22% 73
2021
Q4
$3.95M Sell
139,749
-718
-0.5% -$20.4K 0.4% 47
2021
Q3
$4.02M Buy
140,467
+2,997
+2% +$86.9K 0.4% 41
2021
Q2
$3.97M Sell
137,470
-3,911
-3% -$112K 0.4% 41
2021
Q1
$4M Buy
+141,381
New +$4.09M 0.42% 37

Other funds holding IBDT

Krilogy Financial's IBDT Position: Q3 2026 in Review

Krilogy Financial reduced its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 4.1% in Q3 2026, selling an estimated $211K and leaving 198,736 shares worth $4.96M. The position accounts for 0.14% of the portfolio, ranked #116.

Krilogy Financial first reported a position in IBDT in Q1 2021 and has held it in 23 quarters since. The position peaked at $5.24M in Q4 2025. 107 funds tracked by Wall St. Rank hold IBDT as of Q3 2026.

  • Krilogy Financial held 198,736 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $4.96M as of Q3 2026.
  • Krilogy Financial sold 8,409 iShares iBonds Dec 2028 Term Corporate ETF shares in Q3 2026, an estimated $211K.
  • iShares iBonds Dec 2028 Term Corporate ETF made up 0.14% of Krilogy Financial's portfolio in Q3 2026, its #116 holding.
  • Krilogy Financial first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q1 2021 and has held it in 23 quarters since.
  • Krilogy Financial's iShares iBonds Dec 2028 Term Corporate ETF position peaked at $5.24M in Q4 2025.
  • 107 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q3 2026.

Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.